L-R: Mr Oliver Le Grice (2015 UROP student), Ms Emilia Saminkowicz, Dr Margherita Ghisi, Dr Ross Dickins
Welcome to Dr Ross Dickin's group, new to the Australian Centre for Blood Diseases. Their laboratory is interested in understanding tumour suppressor gene
function, focusing on several hematopoietic transcription factors
recurrently mutated in acute lymphoblastic and myeloid leukemias (ALL
and AML). Cancer results from an accumulation of genetic mutations that disable the normal regulation of cell growth and survival. In the last decade, large scale cancer genome sequencing of all the major cancer types has identified ~150 genes that promote oncogenesis when mutated. The key challenge, they believe, is to understand how these cancer ‘driver genes’, comprising a similar number of oncogenes and tumour suppressor genes, contribute to tumourigenesis and treatment response.
Congratulations to ACBD's Viki Ling who has been awarded a CTx Top Up Clinician researcher PhD scholarship,
Cancer Therapeutics CRC supports careers in drug discovery, in particular through building capacity in translational biology and medicinal chemistry.
CTx is governed by an independent skills-based board and led by a highly experienced management team. The collaborative research and business model allows innovative approaches to drug discovery as well as commercialisation of the research pipeline. The major focus for drug discovery is early intervention in the metastatic cascade.
Central Clinical School has regular seminar series and postgraduate presentations. All event notices are maintained on the CCS Events calendar.
staff & students can see details of both public and local events
(including professional development courses, trade fairs and Graduate
Research Student calendars) and deadlines, at the Intranet's Announcements page.
"Transcriptional network regulating development of Tregs and Th17 cells"
Presented by: Professor Vijay K. Kuchroo, D.V.M., Ph.D.
When: Wednesday 27 May
Time: 12:00noon – 1pm
Where: AMREP Lecture Theatre
Professor Vijay Kuchroo is the Samuel L. Wasserstrom Professor of Neurology at Harvard Medical School, Senior Scientist at Brigham and Women’s Hospital, and Co-Director of the Center for Infection and Immunity, Brigham Research Institutes, Boston. Professor Kuchroo is also an associate member of the Broad Institute and a participant in a Klarman Cell Observatory project that focuses on T cell differentiation.